Effect of luminal surface structure of decellularized aorta on thrombus formation and cell behavior.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 13 01 2021
accepted: 03 05 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 7 10 2021
Statut: epublish

Résumé

Due to an increasing number of cardiovascular diseases, artificial heart valves and blood vessels have been developed. Although cardiovascular applications using decellularized tissue have been studied, the mechanisms of their functionality remain unknown. To determine the important factors for preparing decellularized cardiovascular prostheses that show good in vivo performance, the effects of the luminal surface structure of the decellularized aorta on thrombus formation and cell behavior were investigated. Various luminal surface structures of a decellularized aorta were prepared by heating, drying, and peeling. The luminal surface structure and collagen denaturation were evaluated by immunohistological staining, collagen hybridizing peptide (CHP) staining, and scanning electron microscopy (SEM) analysis. To evaluate the effects of luminal surface structure of decellularized aorta on thrombus formation and cell behavior, blood clotting tests and recellularization of endothelial cells and smooth muscle cells were performed. The results of the blood clotting test showed that the closer the luminal surface structure is to the native aorta, the higher the anti-coagulant property. The results of the cell seeding test suggest that vascular cells recognize the luminal surface structure and regulate adhesion, proliferation, and functional expression accordingly. These results provide important factors for preparing decellularized cardiovascular prostheses and will lead to future developments in decellularized cardiovascular applications.

Identifiants

pubmed: 33999919
doi: 10.1371/journal.pone.0246221
pii: PONE-D-21-01350
pmc: PMC8128234
doi:

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0246221

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Stem Cells. 2014 Mar 13;3(1):1-20
pubmed: 24660110
J Biol Chem. 2009 Feb 6;284(6):3728-38
pubmed: 19088079
Am J Sports Med. 1997 Jan-Feb;25(1):107-12
pubmed: 9006703
J Biomech. 2012 Mar 15;45(5):745-55
pubmed: 22177671
Arch Dermatol. 1998 Oct;134(10):1255-9
pubmed: 9801681
Stroke. 2015 May;46(5):e121-2
pubmed: 25873596
Int J High Throughput Screen. 2010 Oct 1;2010(1):171-181
pubmed: 21278926
ACS Biomater Sci Eng. 2017 Jul 10;3(7):1236-1244
pubmed: 33440512
Bosn J Basic Med Sci. 2020 Feb 05;20(1):21-30
pubmed: 31465719
Biomaterials. 2010 May;31(13):3590-5
pubmed: 20149445
J Mater Chem B. 2020 Dec 23;8(48):10977-10989
pubmed: 33174886
Physiol Rev. 2004 Jul;84(3):767-801
pubmed: 15269336
Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1877-9
pubmed: 20844267
Am Surg. 2006 Jun;72(6):491-6
pubmed: 16808200
Xenotransplantation. 2018 Jan;25(1):
pubmed: 29057501
Baillieres Clin Haematol. 1994 Sep;7(3):441-52
pubmed: 7841594
Semin Immunopathol. 2012 Jan;34(1):93-106
pubmed: 21845431
Nat Commun. 2017 Mar 22;8:14913
pubmed: 28327610
Mater Sci Eng C Mater Biol Appl. 2014 Oct;43:465-71
pubmed: 25175237
Tissue Eng Part B Rev. 2016 Feb;22(1):68-100
pubmed: 26447530
BMC Cardiovasc Disord. 2015 Oct 19;15:130
pubmed: 26481314
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Cardiovasc Res. 2018 Mar 15;114(4):590-600
pubmed: 29514202
Interact Cardiovasc Thorac Surg. 2015 Aug;21(2):189-94
pubmed: 25972596
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2370-7
pubmed: 22011749

Auteurs

Mako Kobayashi (M)

Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan.

Masako Ohara (M)

Department of Bioscience and Engineering, Shibaura Institute of Technology, Minuma-ku, Saitama-shi, Saitama, Japan.

Yoshihide Hashimoto (Y)

Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan.

Naoko Nakamura (N)

Department of Bioscience and Engineering, Shibaura Institute of Technology, Minuma-ku, Saitama-shi, Saitama, Japan.

Toshiya Fujisato (T)

Department of Biomedical Engineering, Osaka Institute of Technology, Asahi-ku, Osaka, Japan.

Tsuyoshi Kimura (T)

Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan.

Akio Kishida (A)

Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH